Company: SWKH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050155
Chunk: 29

Company: SWK Holdings Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 will no longer exist and only the specialty Finance Receivable segment will remain for reporting periods beginning after September 30,2025.

15

The following table summarizes the assets and liabilities held for sale:December 31, 2024Assets:Inventory$354 Property & equipment, net4,635 Intangible assets, net209 Other non-current assets1,200 Total assets held for sale, net$6,398 Liabilities:Accounts payable & accrued liabilities$268 Other non-current liabilities987 Total liabilities held for sale$1,255 During the nine months ended September 30, 2025 and the year ended December 31, 2024, there was not a strategic shift for the Company, and accordingly, the Pharmaceutical Development segment does not meet the criteria to be classified as a discontinued operation. As a result, we will continue to report our operational results for the Pharmaceutical Development segment. The following table shows the net loss before taxes for MOD3 (in thousands):Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Net income (loss) before taxes$660 $(892)$144 $(4,084)Agreement and Plan of Merger

On October 9, 2025, the Company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Runway Growth Finance Corp., a Maryland corporation (“Parent”), RWAY Portfolio Holding Corp., a Delaware corporation and a direct wholly owned subsidiary of Parent (“Intermediary Sub”), RWAY Portfolio Corp., a Delaware corporation and a direct wholly owned subsidiary of Intermediary Sub (“Acquisition Sub”), and Runway Growth Capital LLC, a Delaware limited liability company (“Parent External Adviser”). 

16

Note 5. Marketable Investments

Investments in corporate debt and equity securities consist of the following (in thousands):September 30, 2025December 31, 2024Corporate debt securities$— $21 Equity securities275 559 Total marketable investments$275 $580  The amortized cost basis amounts, gross unrealized holding gains, gross unrealized holding losses and fair values of available-for-sale debt securities are as follows (in thousands):Amortized CostGross Unrealized Gains Gross Unrealized LossesFair ValueDecember 31, 2024$21 $— $— $21 Equity SecuritiesOn May 29, 2025, as part of an amendment